Ara
Toplam kayıt 4, listelenen: 1-4
Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19
(Wiley, 2021)
Hydroxychloroquine (HCQ) and azithromycin (AZM) are widely used in off‐label treatment of novel coronavirus disease (COVID‐19). However, cardiac safety of these drugs is still controversial in COVID‐19. Therefore, we aimed ...
Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients
(Taylor and Francis Ltd., 2021)
Objectives: The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients.
Methods: It was designed as a single center ...
Fragmented QRS is a marker of mortality in patients with severe COVID-19: A retrospective observational study
(TURKISH SOCIETY CARDIOLOGY, 2021)
Objective: In this study, we aimed to investigate the association of fragmented QRS (f-QRS) with in-hospital death in patients with severe novel coronavirus disease 2019 (COVID-19).
Methods: This was a retrospective and ...
Prognostic implication of uncontrolled hypertension in hospitalized patients with COVID-19
(CZECH SOC CARDIOLOGY & CZECH SOC CARDIOVASCULAR SURGERY, 2021)
Objective: In this study, we aimed to investigate the effect of hypertension (HT) and antihypertensive treatment on prognosis, which is one of the cardiovascular risk factors affecting the prognosis of COVID-19.
Methods: ...